CN117100627A - 三因多效护肤组合物 - Google Patents
三因多效护肤组合物 Download PDFInfo
- Publication number
- CN117100627A CN117100627A CN202311309686.8A CN202311309686A CN117100627A CN 117100627 A CN117100627 A CN 117100627A CN 202311309686 A CN202311309686 A CN 202311309686A CN 117100627 A CN117100627 A CN 117100627A
- Authority
- CN
- China
- Prior art keywords
- skin
- skin care
- care composition
- extract
- cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000000694 effects Effects 0.000 claims abstract description 25
- 239000000284 extract Substances 0.000 claims abstract description 18
- 239000002537 cosmetic Substances 0.000 claims abstract description 17
- 239000006071 cream Substances 0.000 claims abstract description 17
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 14
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 claims abstract description 9
- 229940093497 ergothioneine Drugs 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 230000002087 whitening effect Effects 0.000 claims abstract description 9
- 239000003581 cosmetic carrier Substances 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 8
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 7
- 240000008632 Cota tinctoria Species 0.000 claims abstract description 6
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940119217 chamomile extract Drugs 0.000 claims abstract description 5
- 235000020221 chamomile extract Nutrition 0.000 claims abstract description 5
- -1 trimethylol hexyl lactone Chemical class 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 5
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 5
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 5
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 5
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 5
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 5
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 5
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims description 5
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 claims description 5
- 229940036350 bisabolol Drugs 0.000 claims description 5
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 5
- 229920006037 cross link polymer Polymers 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 5
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims description 5
- 229960004881 homosalate Drugs 0.000 claims description 5
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 5
- 229960000601 octocrylene Drugs 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 241000252233 Cyprinus carpio Species 0.000 claims description 4
- 229940114081 cinnamate Drugs 0.000 claims description 4
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 4
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 4
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 4
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims description 3
- 230000008439 repair process Effects 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- UUGLJVMIFJNVFH-UHFFFAOYSA-N Benzoesaeure-n-hexylester Natural products CCCCCCOC(=O)C1=CC=CC=C1 UUGLJVMIFJNVFH-UHFFFAOYSA-N 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 46
- 210000004027 cell Anatomy 0.000 description 8
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 7
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 230000005808 skin problem Effects 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- 108010024636 Glutathione Proteins 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 238000005282 brightening Methods 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108010031318 Vitronectin Proteins 0.000 description 2
- 102100035140 Vitronectin Human genes 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- KOGFZZYPPGQZFZ-QVAPDBTGSA-N (2s,3r,4s,5r)-2-(2-hydroxypropyl)oxane-3,4,5-triol Chemical compound CC(O)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O KOGFZZYPPGQZFZ-QVAPDBTGSA-N 0.000 description 1
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 1
- YPUZOECTETYPRF-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine-2-carboxylic acid Chemical compound OC(=O)C1NCC=CN1 YPUZOECTETYPRF-UHFFFAOYSA-N 0.000 description 1
- XXCRXPYEAMCJKH-UHFFFAOYSA-N 3,3,4-trimethyloxepan-2-one Chemical compound CC1CCCOC(=O)C1(C)C XXCRXPYEAMCJKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- YMBHXZXVFJIHAC-UHFFFAOYSA-N CCCCCCOC(C(C=CC=C1)=C1C(N(CC)CC)=O)=O Chemical compound CCCCCCOC(C(C=CC=C1)=C1C(N(CC)CC)=O)=O YMBHXZXVFJIHAC-UHFFFAOYSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 description 1
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了三因多效护肤组合物，所述护肤组合物包括下述原料组成：玻色因、麦角硫因、四氢甲基嘧啶羧酸、三七根提取物、忍冬花提取物和金黄洋甘菊提取物和余量的面霜常规换妆品载体辅料，其中各组分重量百分比为玻色因3％、麦角硫因0.15％、四氢甲基嘧啶羧酸0.15％、七根提取物、忍冬花提取物和金黄洋甘菊提取物5％、余量的面霜常规换妆品载体辅料89％。本发明与现有技术相比的优点在于：提供一种，配比合理，使用稳定，具有全效美白、抗衰、修复功效的三因多效护肤组合物。
Description
技术领域
本发明涉及化妆品领域，具体是指三因多效护肤组合物。
背景技术
随着年龄的增长，胶原蛋白的缺失，皮下脂肪的减少使面部和身体其它部位都可以出现弹性变差，甚至出现皱纹、色斑；由于熬夜、不按时吃饭或者饮食的营养不够，都可以造成皮肤改变，经常看到一些人由于操劳过度，皮肤显得很憔悴，造成一定的衰老样的皮肤改变；另外，还有日晒，会使皮肤的组织受到破坏，不但形成色素，同时也可以使弹性变差。
另外因年龄的增长容貌渐趋衰老，是自然而然，难以抵挡的天敌。衰老又称老化，是生命活动进程中的必经阶段，皮肤衰老在机体衰老过程中表现最为明显。皮肤衰老不仅会出现皱纹、松弛和色素沉着，同时还会出现表皮新陈代谢降低、表皮修复受损能力和屏障保护能力减弱等问题。
随着现代经济的发展和人们护肤意识的提高，以及对美肌质量的追求，人们对肌肤的护理更加频繁，人们在选择护肤品时，一方面追求绿色、自然、温和、安全和环保的护肤品，另一方面要求就是对所选用的护肤品能够达到较好的效果的同时可以兼具多种功效，但目前现有的产品中，不能同时高效地兼具保湿、修复、紧致、抗衰、提亮、抗敏的功效。
目前市场上的化妆品原料其功效往往比较单一，配方师需要根据经验将多种化妆品原料调配在一起，使得目标化妆品能够具有多重功效，但是该工作在很大程度上依赖于配方师的经验，成功率较低，且经常容易出现将多种化妆品原料组合在一起后，其功效反而变差的问题。
在CN106109362 A公开了一种抗衰老组合物、抗衰老化妆品及其制备方法。本发明所述抗衰老组合物中，通过将车前草籽提取物、羽扇豆提取物以及荷花提取物复配使用，从而能够有效预防和改善皮肤老化，并能够紧致皮肤，并起到抗皮肤衰老的作用，但其只针对了皮肤皱纹的淡化和皮肤弹性的改善，也并不能缓解皮肤的衰老的干燥、粗糙、暗淡和敏感等问题。
在113679628A中公开了一种综合改善皮肤问题的护肤组合物及其应用。所述护肤组合物对依克多因、麦角硫因、玻色因、谷胱甘肽和乙酰基六肽-8即“三因两肽”五种成分进行组合，形成的组合物具有强大的综合修复皮肤问题的功效。然而其主要成分之一的谷胱甘肽的稳定性很差，还原型谷胱甘肽溶解到水溶液中，室温下只能保存2个小时，在0-5℃下，也仅能保存8个小时，这一缺陷限制了其功效发挥。添加“谷胱甘肽”的化妆品很多，但绝大多数都无法发挥其本来的作用。
为此我们提出另一种结合三因组合物，等多种成分的具有全效美白、抗衰、修复功效的化妆品组合物。
发明内容
本发明要解决的技术问题是，克服以上技术缺陷，提供一种，配比合理，使用稳定，具有全效美白、抗衰、修复功效的三因多效护肤组合物。
为解决上述技术问题，本发明提供的技术方案为：三因多效护肤组合物，所述护肤组合物包括下述原料组成：玻色因、麦角硫因、四氢甲基嘧啶羧酸、三七根提取物、忍冬花提取物和金黄洋甘菊提取物和余量的面霜常规换妆品载体辅料，其中各组分重量百分比为玻色因3％、麦角硫因0.15％、四氢甲基嘧啶羧酸0.15％、七根提取物、忍冬花提取物和金黄洋甘菊提取物5％、余量的面霜常规换妆品载体辅料89％。
优选的，所述的面霜常规换妆品载体辅料还包括水杨酸乙基己酯、乙基己基三嗪酮、碳酸二辛酯、奥克立林、三羟甲基己基内酯交联聚合物、乙醇、甲氧基肉桂酸乙基已酯、丁羟甲苯、胡莫柳酯、醇苯甲酸酯、二乙氨羟苯甲酰基苯甲酸己酯、双-乙基己氧苯酚甲氧苯基三嗪、聚二甲基硅氧烷、硅石、聚甲基硅氧烷、聚甲基倍半硅氧烷、红没药醇、二硬脂二甲铵鲤蒙脱石、双丙甘醇、日用香精。
面霜的制备方法包括按重量百分比称量各组分原料，将各组分依次加入反应釜混合搅拌均匀，即获得一种具有全效美白抗衰修复功效的面霜。
本发明还提供了面霜在制备具有全效美白抗衰修复功效的化妆品中的用途。
水杨酸乙基己酯，可以促进皮肤细胞的新生，提亮肤色，改善肤质，去除角质，减少皱纹和痘痘痕迹。
乙基己基三嗪酮为抗氧化剂，具有抗衰老和抗自由基的作用，可以减轻皮肤的氧化损伤和提供保护。
碳酸二辛酯为乳化剂，具有良好的分散性和稳定性，可以加强化妆品的质地和延长保质期。
奥克立林可以阻挡紫外线的侵害，减少皮肤的色斑和皱纹的产生。
三甲基己基内酯交联聚合物可以提供皮肤的保湿效果，并增加化妆品的质地和稠度。
三七根提取物为植物提取物，具有抗炎和抗氧化的作用，可以舒缓皮肤，减轻红肿和炎症。
忍冬花提取物为植物提取物，具有美白和抗衰老的作用，可以均匀肤色，减少细纹和色斑的产生。
乙醇：具有消毒和溶解作用，可以帮助其他成分更好地渗透皮肤。
甲氧基肉桂酸乙基已酯：具有防晒作用，可以保护皮肤免受紫外线伤害。
丁羟甲苯：具有保湿和柔软肌肤的作用。
胡莫柳酯：具有抗菌和抗炎作用，可以改善肌肤问题。
醇苯甲酸酯：具有抗炎和镇静作用，可以舒缓敏感皮肤。
二乙氨羟苯甲酰基苯甲酸己酯：具有抗氧化和抗衰老作用，可以改善皮肤弹性和紧致度。
双-乙基己氧苯酚甲氧苯基三嗪：具有抗炎和抗氧化作用，可以帮助减少皮肤炎症和提亮肤色。
聚二甲基硅氧烷、硅石、聚甲基硅氧烷、聚甲基倍半硅氧烷：这些硅基化合物常用作化妆品的填充剂和润滑剂，可以增加产品的光滑度和延展性。
红没药醇：具有抗菌和抗炎作用，可以改善皮肤问题。
二硬脂二甲铵鲤蒙脱石：具有吸附和清洁作用，可以去除皮肤表面的污垢和杂质。
双丙甘醇：具有保湿和柔软肌肤的作用。
本发明与现有技术相比的优点在于：在本发明中护肤组合物中的成分包括玻色因、麦角硫因、四氢甲基嘧啶羧酸(依克多因)、烟酰胺和复合维生素等，对皮肤有多种益处，如抗氧化、保湿、平衡油脂、提亮肤色等，可以提供多效护肤效果，而结合面霜常规用品使用，可提供综合保养，保持皮肤的滋润和柔软，易于应用和吸收，可以方便地融入日常护肤程序中。
具体实施方式
下面对本发明做进一步的详细说明。
结合所示，三因多效护肤组合物，所述护肤组合物包括下述原料组成：玻色因、麦角硫因、四氢甲基嘧啶羧酸、三七根提取物、忍冬花提取物和金黄洋甘菊提取物和余量的面霜常规换妆品载体辅料，其中各组分重量百分比为玻色因3％、麦角硫因0.15％、四氢甲基嘧啶羧酸0.15％、七根提取物、忍冬花提取物和金黄洋甘菊提取物5％、余量的面霜常规换妆品载体辅料89％。
依克多因，即四氢甲基嘧啶羧酸，是一种两性的稀有氨基酸，由生活中极端环境中的细菌产生。依克多因是目前发现的细菌界分布最广泛的相容性溶质，它与细胞内的新陈代谢相关，具有保护上皮细胞，稳定细胞膜，滋润皮肤并减少炎症产生的作用。
麦角硫因，可以通过角质形成细胞和纤维细胞中的转运体OCTN-1转运进入细胞和线粒体内，清除活性氧自由基，从而发挥抗氧化、减少细胞凋亡、提高细胞活力、保护细胞的作用。本发明意外发现将麦角硫因应用于护肤品中能够有效的减少皮肤色斑和细纹的产生，改善皮肤粗糙度，提高皮肤弹性。
玻色因，即羟丙基四氢吡喃三醇，其进入皮肤，可促进细胞外基质中称为蛋白质多糖的生成和构建(例如凝胶状的蛋白质网络和作为支架及细胞间减震器的糖)。这些分子吸收水分，使基质呈凝胶状，增加细胞及皮肤的紧致度。它还可以作为指引修复分子(譬如细胞生长的蛋白质)通行的通道。随着皮肤老化，细胞外基质会逐渐失去弹性；细胞开始变坏，不能再生产促进年轻态的蛋白质，如胶原蛋白。玻色因利用细胞外基质的活动通知衰老的细胞该怎么做，给年轻细胞发送信息，同时重新刺激老化的细胞。
其中玻色因3％、麦角硫因0.15％、四氢甲基嘧啶羧酸(依克多因)0.15％、七根提取物、忍冬花提取物和金黄洋甘菊提取物5％、余量的面霜常规换妆品载体辅料89％。
还包括水杨酸乙基己酯、乙基己基三嗪酮、碳酸二辛酯、奥克立林、三羟甲基己基内酯交联聚合物、乙醇、甲氧基肉桂酸乙基已酯、丁羟甲苯、胡莫柳酯、醇苯甲酸酯、二乙氨羟苯甲酰基苯甲酸己酯、双-乙基己氧苯酚甲氧苯基三嗪、聚二甲基硅氧烷、硅石、聚甲基硅氧烷、聚甲基倍半硅氧烷、红没药醇、二硬脂二甲铵鲤蒙脱石、双丙甘醇、日用香精。
上述各项成分满足上述特定的质量配比关系时，其在保湿、美白、抗氧化、紧致肌肤、提亮肌肤方面的协同促进效果更佳显著。
本实施例提供一种综合改善皮肤问题的面霜，其配方组成与上述配方比的区别仅在于增加七根提取物、忍冬花提取物和金黄洋甘菊提取物至10％相应的减少余量的面霜常规换妆品载体辅料占比，组合其他条件均保持不变。
对于水杨酸乙基己酯、乙基己基三嗪酮、碳酸二辛酯、奥克立林、三羟甲基己基内酯交联聚合物、乙醇、甲氧基肉桂酸乙基已酯、丁羟甲苯、胡莫柳酯、醇苯甲酸酯、二乙氨羟苯甲酰基苯甲酸己酯、双-乙基己氧苯酚甲氧苯基三嗪、聚二甲基硅氧烷、硅石、聚甲基硅氧烷、聚甲基倍半硅氧烷、红没药醇、二硬脂二甲铵鲤蒙脱石、双丙甘醇、日用香精的实施使用，根据不同的生产需要调控配比。
本说明书中未作详细描述的内容属于本领域专业技术人员公知的现有技术。
以上对本发明及其实施方式进行了描述，这种描述没有限制性。总而言之如果本领域的普通技术人员受其启示，在不脱离本发明创造宗旨的情况下，不经创造性的设计出与该技术方案相似的结构方式及实施例，均应属于本发明的保护范围。
Claims (4)
1.三因多效护肤组合物，其特征在于：所述护肤组合物包括下述原料组成：玻色因、麦角硫因、四氢甲基嘧啶羧酸、三七根提取物、忍冬花提取物和金黄洋甘菊提取物和余量的面霜常规换妆品载体辅料，其中各组分重量百分比为玻色因3％、麦角硫因0.15％、四氢甲基嘧啶羧酸0.15％、七根提取物、忍冬花提取物和金黄洋甘菊提取物5％、余量的面霜常规换妆品载体辅料89％。
2.根据权利要求1所述的三因多效护肤组合物，其特征在于：所述的面霜常规换妆品载体辅料还包括水杨酸乙基己酯、乙基己基三嗪酮、碳酸二辛酯、奥克立林、三羟甲基己基内酯交联聚合物、乙醇、甲氧基肉桂酸乙基已酯、丁羟甲苯、胡莫柳酯、醇苯甲酸酯、二乙氨羟苯甲酰基苯甲酸己酯、双-乙基己氧苯酚甲氧苯基三嗪、聚二甲基硅氧烷、硅石、聚甲基硅氧烷、聚甲基倍半硅氧烷、红没药醇、二硬脂二甲铵鲤蒙脱石、双丙甘醇、日用香精。
3.根据权利要求1-2任一所述的面霜的制备方法，其特征在于：按重量百分比称量各组分原料，将各组分依次加入反应釜混合搅拌均匀，即获得一种具有全效美白抗衰修复功效的面霜。
4.根据权利要求1-2任一所述的面霜或采用权利要求3制备方法制得的面霜在制备具有全效美白抗衰修复功效的化妆品中的用途。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311309686.8A CN117100627A (zh) | 2023-10-11 | 2023-10-11 | 三因多效护肤组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311309686.8A CN117100627A (zh) | 2023-10-11 | 2023-10-11 | 三因多效护肤组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117100627A true CN117100627A (zh) | 2023-11-24 |
Family
ID=88807729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311309686.8A Pending CN117100627A (zh) | 2023-10-11 | 2023-10-11 | 三因多效护肤组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117100627A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117860638A (zh) * | 2024-01-11 | 2024-04-12 | 广州市科臣生物技术有限公司 | 一种含有玻色因的修护抗衰组合物的制备方法和应用 |
-
2023
- 2023-10-11 CN CN202311309686.8A patent/CN117100627A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117860638A (zh) * | 2024-01-11 | 2024-04-12 | 广州市科臣生物技术有限公司 | 一种含有玻色因的修护抗衰组合物的制备方法和应用 |
| CN117860638B (zh) * | 2024-01-11 | 2024-08-02 | 广州市科臣生物技术有限公司 | 一种含有玻色因的修护抗衰组合物的制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101414702B1 (ko) | 피부재생, 항염 및 피부진정용 화장료 조성물 및 그 제조방법 | |
| CN117100627A (zh) | 三因多效护肤组合物 | |
| US9480864B2 (en) | Marine based cosmetic active ingredients and use thereof | |
| JP4336486B2 (ja) | ヒアルロン酸産生促進剤 | |
| CN109330954B (zh) | 美白亮肤水及其制备方法和酪氨酸酶抑制剂 | |
| KR102499608B1 (ko) | 리쥬버네이팅 세럼형 화장료 조성물 및 그 제조방법 | |
| CN111803422B (zh) | 一种控油组合物及其应用 | |
| KR102088728B1 (ko) | 식물 복합추출물을 유효성분으로 함유하는 피부 탄력 및 주름 개선용 화장료 조성물 | |
| JP2008088098A (ja) | 美白剤及びこれを含有する皮膚外用剤 | |
| KR101948828B1 (ko) | 기능성 펩타이드, 성장인자 및 귤속 과피 발효물을 포함하는 피부 재생, 주름 개선 또는 항산화용 조성물 | |
| KR102040688B1 (ko) | 산자나무 열매 추출물을 함유하는 화장료 조성물 | |
| KR102544792B1 (ko) | 락토바실러스 브레비스 균주로 발효한 해조류 복합 발효 추출물을 유효성분으로 포함하는 피부 탄력 또는 피부 주름 개선, 항산화 및 피부 보습용 조성물 | |
| CN113786371A (zh) | 一种制备越橘海藻面膜的组合物、面膜及制备方法 | |
| KR101756306B1 (ko) | 무환자 추출물을 함유하는 구강용 조성물 | |
| JP2017025034A (ja) | 化粧品類 | |
| US20210000726A1 (en) | Composition for enhancing skin elasticity or improving skin wrinkles comprising heptahydroxyflavan as an effective ingredient | |
| KR100966836B1 (ko) | 두피 보호 및 피부 진정 효과를 가지는 화장료 조성물 | |
| JP2002370962A (ja) | 美白用化粧料および皮膚老化防止・改善用化粧料 | |
| EP3324923A1 (en) | Compositions and methods using palythine | |
| KR102499606B1 (ko) | 리쥬버네이팅 크림형 화장료 조성물 및 그 제조방법 | |
| KR102499610B1 (ko) | 리쥬버네이팅 스킨 소프너형 화장료 조성물 및 그 제조방법 | |
| KR20160020242A (ko) | 파르테노리드를 포함하는 흑화, 탄력, 주름개선, 또는 보습용 화장료 또는 약학 조성물 | |
| US20230172825A1 (en) | Composition for improving skin comprising amino acid complex as active ingredient | |
| KR102499607B1 (ko) | 리쥬버네이팅 아이크림형 화장료 조성물 및 그 제조방법 | |
| CN115919698B (zh) | 一种紧致抗皱功效组合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |